Delivery Order SPE2DR25D3005-SPE2DR26FP8PD
- Not listed
- AmerSourceBergen Drug Corp was awarded a delivery order valued at $2,208.66 by the Defense Logistics Agency (DLA) on April 24, 2025, for the supply of Concerta ER 36 mg tablets (100-count packages). The contract is a firm fixed price delivery order with an ultimate completion date of April 25, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation and represents a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 12, 2026, for the supply of Concerta ER 36 mg tablets (100-count units) valued at $11,601.13, with a completion date of January 13, 2026. This is a firm fixed-price, non-set-aside contract performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order by the Defense Logistics Agency on January 12, 2026, for 100 tablets of Concerta ER 36 mg with a ceiling value of $10,816.43. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of January 13, 2026, and will be performed at the awardee's location in Conshohocken, Pennsylvania. This award was made on a non-set-aside, competitive basis. This delivery order is issued...
- The Defense Logistics Agency awarded a $3,301.25 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Concerta ER 36 mg, with an ultimate completion date of July 25, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. The...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $39,633.84 to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Concerta ER tablets 36mg. This is a firm fixed-price, non-set-aside contract with a completion date of August 7, 2025, and will be performed at the vendor's Corporate Office location in Conshohocken, PA. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement,...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $5,413.32 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 4,564,287,331 units of the pharmaceutical product Concerta ER 36 mg tablets. This order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA to provide a comprehensive range of pharmaceutical products and medical supplies to support Department of...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for 36mg Concerta ER tablets valued at $14,709.30 under a firm fixed price contract type. The award was made on September 17, 2025, with an ultimate completion date of September 18, 2025, and represents a competitive, non-set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $11,369.76 to AmerisourceBergen Drug Corp for Concerta ER 36 mg tablets (100-count units) on December 5, 2025, with a completion date of December 8, 2025. This firm fixed price, non-set-aside contract represents a small-value transaction within the pharmaceutical supply chain supporting federal medical procurement needs. The delivery will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Concerta ER 36 mg tablets (100 count) valued at $2,922.27. This is a firm fixed price delivery order with no set-aside designation, issued under a competitive procurement process. The product will be delivered to the Conshohocken, Pennsylvania location, with a completion date of November 4, 2025. This award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Concerta ER Tablets 36mg with a ceiling value of $15,818.06. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle and involves no set-aside designation. The award was made competitively and will be performed at the...
- SPE2DR25D3005Indefinite Delivery Contract
- SPE2DR25D3005-SPE2DR26FP8PDDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,185.08 to AmerSourceBergen Drug Corp for the supply of Concerta ER 36 mg tablets (100 count) on January 13, 2026, with an ultimate completion date of January 14, 2026. This firm fixed-price, non-set-aside contract was performed at the awardee's location in Conshohocken, Pennsylvania. The delivery order represents a task order under AmerSourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally. AmerSourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor that supplies a comprehensive range of medical commodities including brand-name and generic medications, vaccines, and specialized healthcare products to federal agencies. The company competes on a full and open basis for federal contracts and has demonstrated capability in fulfilling government procurement requirements across multiple therapeutic domains. This award reflects the company's ongoing role as a critical vendor in the Defense Health Agency's pharmaceutical supply chain, delivering essential medications to military treatment facilities and other federal medical institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.2k | 1/12/26 |